<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>CARDIOVASCULAR SUPPORT</title><link href="navigation.css" rel="stylesheet" type="text/css"/><link href="document.css" rel="stylesheet" type="text/css"/></head><body><p class="top_nav"><a href="part20.htm">&lt; Назад</a><span> | </span><a href="index.html">Содержимое</a><span> | </span><a href="part22.htm">Далее &gt;</a></p><h4 style="padding-top: 12pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">CARDIOVASCULAR SUPPORT</h4><p class="s11" style="padding-top: 4pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Lipid Stabil™</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s163" style="padding-top: 5pt;padding-left: 6pt;text-indent: 0pt;text-align: left;"><a name="bookmark1681">Description:</a></p><p style="padding-top: 8pt;padding-left: 6pt;text-indent: 0pt;line-height: 117%;text-align: justify;">Lipid Stabil is a cholesterol and cardiovascular health support supplement. It was specifically designed to be a foundation supplement for steroid users, and is especially useful during on-cycle periods. The formula specifically focuses  on  supporting  four  separate  areas  of cardiovascular  health:  1)  reducing  LDL  (low-density lipoprotein) &quot;bad&quot; cholesterol; 2) increasing beneficial HDL (high-density lipoprotein) cholesterol; 3) reducing serum triglycerides; and 4) reducing oxidative stress and arterial plaque  formation.  Antioxidant  supplementation  is  an important  and  often  overlooked  part  of  managing cardiovascular health during anabolic/androgenic steroid use, as AAS are known to increase homocysteine levels and oxidative stress. Although no supplement can completely eliminate  the  cardiovascular  risks  of  AAS  abuse,  a supplement such as Lipid Stabil (or one with a similar ingredient profile) is highly recommended, as it may help reduce  the  lasting  negative  health  impact  of  these medications.</p><p style="padding-top: 6pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;"><a name="bookmark1682">Lipid Stabil contains a comprehensive blend of nearly one dozen natural ingredients. Each component in known to play an important role in cardiovascular health, and many have significant clinical support demonstrating beneficial effects on key health markers. For example, garlic powder is one of the backbone ingredients, and has been shown in studies  to  increase  HDL  cholesterol,  reduce  LDL cholesterol, and improve the antioxidant response.</a><span class="s33">1  2 </span>Green tea extract (standardized for EGCG and high polyphenol content) is another backbone ingredient, and like garlic, is also shown to improve cholesterol and reduce oxidative stress/LDL oxidation.<span class="s33">3 4 </span>Several other clinically studied ingredients known to improve cholesterol levels, serum triglycerides, and/or systemic antioxidant capacity round out the Lipid Stabil formula including resveratrol,<span class="s33">5 </span>phytosterols,<span class="s33">6  </span>policosanol,<span class="s33">7  </span>selenium,<span class="s33">8  </span>and  inositol hexanicotinate (no-flush niacin).<span class="s33">9</span></p><p class="s163" style="padding-top: 7pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">History:</p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;"><a name="bookmark1683">Lipid Stabil was developed in 2008 by Molecular Nutrition (U.S.).  The  focus  was  specifically  on  designing  a supplement that can help support cardiovascular health in anabolic/androgenic steroid users. The product can be found through international distribution, although it may possibly be considered a drug product in some regions with strict controls on herbal supplement products.</a></p><p class="s163" style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">How Supplied:</p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Each serving of Lipid Stabil is supplied in 3 capsules, and</p><p style="padding-top: 4pt;padding-left: 6pt;text-indent: 0pt;line-height: 117%;text-align: justify;">contains a blend of green tea extract (750 mg), garlic powder  (600  mg),  inositol  hexanicotinate  (400  mg), polygonum cuspidatum standardized for resveratrol (200 mg), pantothenic acid (100 mg), phytosterol complex (100 mg), policosanol (10 mg),and selenium (200 mcg).</p><p class="s163" style="padding-top: 6pt;padding-left: 6pt;text-indent: 0pt;text-align: left;"><a name="bookmark1684">Side Effects:</a></p><p style="padding-top: 8pt;padding-left: 6pt;text-indent: 0pt;line-height: 118%;text-align: justify;"><a name="bookmark1685">Lipid Stabil is a natural dietary supplement and is not expected to have notable side effects.</a></p><p class="s163" style="padding-top: 6pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Administration:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;">For general cholesterol and lipid support or as an adjunct to anabolic/androgenic steroid use,Lipid Stabil is generally taken at a dosage of 3 capsules per day. Note that a natural product  such  as  Lipid  Stabil  may  help  reduce cardiovascular toxicity, but cannot be relied upon to completely  eliminate  potential  cardiovascular  damage from the abuse of anabolic/androgenic steroid drugs. Care should always be taken to monitor all aspects of health when taking AAS substances.</p><p class="s163" style="padding-top: 7pt;padding-left: 6pt;text-indent: 0pt;text-align: left;"><a name="bookmark1686">Availability:</a></p><p style="padding-top: 8pt;padding-left: 6pt;text-indent: 0pt;line-height: 117%;text-align: justify;">Lipid Stabil is produced in the U.S. by Molecular Nutrition. <span style=" color: #393939;">It </span>is available for export, and may be found in Canada, Europe, and other international markets.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s68" style="padding-top: 8pt;padding-left: 5pt;text-indent: 4pt;text-align: left;">1  <span class="s67">Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Kojuri J, Vosoughi AR. Akrami M. Lipids Health Dis. 2007 Mar 1;6:5.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: justify;">2  <span class="s67">Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. Durak I, Kavutcu M, Ayta; B, Avci A, Devrim E, Ozbek H, Ozturk HS. J Nutr Biochem. 2004 Jun;15(6):373-7.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: justify;">3  <span class="s67">Antioxidative activity of green tea polyphenol in cholesterol-fed rats. Yokozawa T, Nakagawa T, Kitani K. J Agric Food Chern. 2002 Jun 5;50(12):3549-52.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: left;">4  <span class="s67">Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Gomikawa S, Ishikawa Y. et al. Kobe J Med Sci. 2008 May 23;54(1 ): E62-72.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 3pt;text-align: left;">5  <span class="s67">Cardiovascular protective effects of resveratrol, Bradamante S, Barenghi L, Villa A.Cardiovasc Drug Rev. 2004 Fall;22(3): 169-88.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 3pt;text-align: justify;">6  <span class="s67">Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. Moruisi KG, Oosthuizen W, Opperman AM. J Am Coll Nutr. 2006 Feb;25(1):41-8. Review.</span></p><p class="s68" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: left;">7  <span class="s67">Role of policosanols in the prevention and treatment of cardiovascular disease. Varady KA, Wang Y, Jones PJ. Nutr Rev. 2003 Nov;61 (11 ):376-83. Review.</span></p><p class="s67" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: justify;"><span class="s68">8  </span>Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Huang K, Liu H, Chen Z, Xu <span style=" color: #393939;">H. </span>Atherosclerosis. 2002 May;162(1):137-44.</p><p class="s68" style="padding-top: 1pt;padding-left: 9pt;text-indent: 0pt;text-align: justify;">9 <span class="s67">Inositol hexaniacinate. Altern Med Rev. 1998 Jun;3(3}:222-3.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s5" style="padding-top: 4pt;text-indent: 0pt;text-align: center;">553</p><p class="s11" style="padding-top: 4pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Lovaza® (omega-3 ethyl esters)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s163" style="padding-top: 4pt;padding-left: 6pt;text-indent: 0pt;text-align: left;"><a name="bookmark1687">Description:</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;">Lovaza is a prescription omega-3-acid supplement which contains ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It is fundamentally similar to most over-the-counter fish oil supplements, except that Lovaza is highly purified to drug quality standards, is made with a high (90%) concentration of omega-3 acids, and has gone through extensive clinical trials for a specified therapeutic use. Otherwise, the benefits of EPA/DHA should be reproducible with any quality mercury-free fish oil supplement. In the U.S., Lovaza is approved to lower triglycerides in patients with very high triglyceride levels (&gt;500  mg/dL).  Clinical  studies  showed  triglyceride reductions by as much as 45% with its use.<span class="s33">1 2 </span>In addition, this prescription supplement has been shown to increase HDL (good) cholesterol levels, improve lipoprotein particle size and subclass distribution,<span class="s33">3 </span>and reduce cardiovascular mortality in some patients by 30%.<span class="s33">4 </span>EPA/DHA supplements are commonly taken by anabolic/androgenic steroid users in an effort to reduce the negative cardiovascular effects of AAS.</p><p style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: left;"><a name="bookmark1688">The mechanism of action of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is not fully understood. These omega-3 acids appear to exert their favorable properties over serum lipids through a number of different but complimentary pathways. For one, EPA and DHA appear to be effective at increasing the enzyme hepatic lipoprotein lipase,</a><span class="s33">5 </span>which can increase the excretion of LDL cholesterol and triglycerides. These omega-3 acids may also  increase  mitochondrial  and  peroxisomal  beta­ oxidation, reducing the availability of fatty acids for lipid synthesis.<span class="s33">6</span>They may also suppress nuclear SREBP-1, which reduces hepatic lipogenesis.<span class="s33">7 </span>EPA and DHA also appear to decrease  the  activity  of  the  triglyceride-synthesizing enzyme diacylgylcerol acyltranferase.<span class="s33">8 </span>The lipid reducing actions of EPA and DHA, therefore, appear to be several fold, including reduced substrate availability, reduced lipid synthesis, and increased lipid breakdown.</p><p class="s163" style="padding-top: 7pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">History:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;">The first prescription drug product containing omega-3 acids  was  approved  by  the  U.S.  Food  and  Drug Administration in 2004. <span style=" color: #393939;">It </span>was sold in this market under the Omacor brand name until 2007, when the manufacturer, Reliant Pharmaceuticals, changed the name of the product to Lovaza. This was done to eliminate any confusion with the blood clotting medication Amicar (aminocaproic acid). Lovaza  is  presently  distributed  in  the  U.S.  by  the international drug manufacturer GlaxoSmithKline.</p><p class="s163" style="padding-top: 5pt;padding-left: 6pt;text-indent: 0pt;text-align: left;"><a name="bookmark1689">How Supplied:</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;"><a name="bookmark1690">Lovaza is supplied in soft gelatin capsules containing approximately 900 mg of omega-3-acids each. The doage consists mainly of eicosapentaenoic acid (465 mg) and docosahexaenoic acid (375 mg).</a></p><p class="s163" style="padding-top: 6pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Side Effects:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;line-height: 115%;text-align: justify;">Lovaza is a natural dietary product and is not expected to have notable side effects. A small percentage of patients reported  mild  adverse  reactions during  clinical trials, including back pain <span style=" color: #7A7A7A;">(2.2%), </span>flu symptoms (3.5%), infection <span style=" color: #7A7A7A;">(4.4%), </span>pain <span style=" color: #7A7A7A;">(1.8%), </span>angina pectoris (1.3%), indigestion</p><p class="s41" style="padding-left: 6pt;text-indent: 0pt;line-height: 10pt;text-align: justify;"><a name="bookmark1691">(4.9%), </a><span style=" color: #5E5E5E;">burping </span>(4.9%), <span style=" color: #5E5E5E;">rash </span>(1.8%),<span style=" color: #5E5E5E;">and altered taste </span>(2.7%).</p><p class="s163" style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Administration:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 115%;text-align: justify;">Lovaza is prescribed <span style=" color: #393939;">in </span>a dosage of 4 capsules per day for the treatment of very high triglycerides. Given high cost and limited access, Lovaza is not commonly taken by AAS users. Instead, most steroid users will administer 4-6 grams per day of a quality fish oil supplement for general cholesterol and lipid support. Note that a supplement or prescription drug containing the omega-3-acids EPA and DHA may help reduce cardiovascular toxicity, but cannot be relied upon to completely eliminate potential damage from the abuse of anabolic/androgenic steroid drugs.Care should always be taken to monitor all aspects of health <span style=" color: #7A7A7A;">when </span>taking AAS substances.</p><p class="s163" style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Availability:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 117%;text-align: justify;">High concentration omega-3 acid is marketed as a prescription drug product in the U.S. under the Lovaza brand name. Lovaza is also sold in select European and Asian markets.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s66" style="padding-top: 8pt;padding-left: 10pt;text-indent: 0pt;text-align: left;"><span class="s68">1 </span>Pownall JH et al, Atherosclerosis. <span style=" color: #5E5E5E;">1</span>999; 143:285-297</p><p class="s66" style="padding-top: 1pt;padding-left: 9pt;text-indent: 0pt;text-align: left;"><span class="s65">2 </span>Harris WS et <span style=" color: #5E5E5E;">al, </span>J Cardio Risk 1997;4:385-391</p><p class="s66" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: left;"><span class="s68">3  </span>Clinical overview <span style=" color: #5E5E5E;">of </span>Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Bays H. Am J Cardiol. 2006 Aug 2<span style=" color: #5E5E5E;">1 </span>;98(4A):711- 76i. Epub 2006 May 30.</p><p class="s65" style="padding-top: 1pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">4 <span class="s66">Gissi P Study, The Lancet 1999; Vol 354:447-55</span></p><p class="s65" style="padding-top: 1pt;padding-left: 5pt;text-indent: 3pt;text-align: justify;">5  <span class="s66">Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance.ParkY.Harris WSJ Lipid Res.2003 Mar;44(3):455-63. Epub 2002 Dec 1.</span></p><p class="s66" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: justify;"><span class="s65">6  </span>The hypotriglyceridemic effect of eicosapentaenoic acid <span style=" color: #5E5E5E;">in rats </span>is reflected in increased mitochondrial <span style=" color: #5E5E5E;">fatty acid </span>oxidation followed <span style=" color: #5E5E5E;">by </span>diminished lipogenesis. Willumsen <span style=" color: #5E5E5E;">N, </span>Skorve J, <span style=" color: #5E5E5E;">Hexeberg </span>S, <span style=" color: #5E5E5E;">Rustan </span>AC, Berge RK. Lipids. 1993 Aug;28(8):683-90.</p><p class="s66" style="padding-top: 1pt;padding-left: 5pt;text-indent: 4pt;text-align: left;"><span class="s68">7  </span>Docosahexaenoic acid (DHA) and hepatic gene transcription. Jump DB. Botolin D, Wang Y, Xu J, Demeure O, Christian B. Chem Phys Lipids. 2008 May;153(1 ):3-<span style=" color: #5E5E5E;">1</span>3. Epub 2008 Feb 23.</p><p class="s66" style="padding-top: 1pt;padding-left: 6pt;text-indent: 3pt;text-align: left;"><span class="s65">8  </span>Why do omega-3 <span style=" color: #5E5E5E;">fatty </span>acids lower <span style=" color: #5E5E5E;">serum </span>triglycerides? <span style=" color: #5E5E5E;">Harris WS, </span>Bulchandani D, Curr Opin Lipidol. 2006 Aug;17(4):387-93.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="nav">&nbsp;&nbsp;</p><p class="nav">&nbsp;</p><p class="nav"><a href="part20.htm">&lt; Назад</a><span> | </span><a href="index.html">Содержимое</a><span> | </span><a href="part22.htm">Далее &gt;</a></p><p class="nav">&nbsp;&nbsp;</p></body></html>
